Physician profile
Jae Kim
NPI 1841264918
$2,831.95
in general payments reported to CMS, 2019-2025
19 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $493 · 2021: $367 · 2022: $243 · 2023: $593 · 2024: $500 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $546.55 | 2019-2025 | Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $542.69 | 2019-2024 | Verquvo, Gardasil 9, Vaxelis |
| Lilly USA, LLC | $356.60 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.45 | 2019-2025 | Jardiance |
| Abbvie INC. | $193.47 | 2022-2025 | |
| Pfizer INC. | $186.54 | 2020-2023 | |
| Glaxosmithkline, LLC. | $183.31 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $147.70 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $102.57 | 2020-2025 | Otezla, Repatha, Otezla |
| Sun Pharmaceutical Industries INC. | $75.78 | 2023-2024 | Cequa |
| Corcept Therapeutics | $56.16 | 2025 | Korlym |
| Dexcom, INC. | $53.85 | 2022-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $36.69 | 2025 | Symplicity G3 |
| Exact Sciences Corporation | $24.46 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $23.84 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $23.46 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.32 | 2024 | |
| Organon LLC | $13.69 | 2023 | Nexplanon |
| Phathom Pharmaceuticals, INC. | $11.82 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jae Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.